Enkefalos Biosciences
San Diego, US · Founded 2021 · Delaware corporation
Founders & leadership
DM
Duncan McGregorNamed on SEC filing
WZ
Wei ZhaoNamed on SEC filing
VS
Vaughn SmiderNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$1.5M disclosed across 1 round · 2021
▶$1.5MraisedSep 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Duncan McGregorExecutive Officer, Director
- Wei ZhaoDirector
- Vaughn SmiderExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $1.5M
- Proceeds to insiders
- $110K
- First sale
- Sep 2021
- Incorporated
- Corporation, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Enkefalos Biosciences raised?
- Enkefalos Biosciences has disclosed $1.5M raised across 1 round.
- Where is Enkefalos Biosciences headquartered?
- Enkefalos Biosciences is headquartered in San Diego, US.